NASH Treatment Market Accelerates as Rezdiffra and Wegovy Establish Fibrosis-Defined Drug Pathways, Says Strategic Market Research
Global NASH Treatment Market to grow from USD 8.75 billion in 2025 to USD 46.87 billion by 2032 as first drug approvals, GLP-1 competition, fibrosis testing, and payer-defined patient eligibility reshape MASH care SAMBALPUR, India, July 16, 2026 /PRNewswire/ -- The Global Non-Alcoholic...
Global NASH Treatment Market to grow from USD 8.75 billion in 2025 to USD 46.87 billion by 2032 as first drug approvals, GLP-1 competition, fibrosis testing, and payer-defined patient eligibility reshape MASH care SAMBALPUR, India, July 16, 2026 /PRNewswire/ -- The Global Non-Alcoholic...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.